85 related articles for article (PubMed ID: 17420726)
1. Downregulation of Sef, an inhibitor of receptor tyrosine kinase signaling, is common to a variety of human carcinomas.
Zisman-Rozen S; Fink D; Ben-Izhak O; Fuchs Y; Brodski A; Kraus MH; Bejar J; Ron D
Oncogene; 2007 Sep; 26(41):6093-8. PubMed ID: 17420726
[TBL] [Abstract][Full Text] [Related]
2. Alternative splicing generates an isoform of the human Sef gene with altered subcellular localization and specificity.
Preger E; Ziv I; Shabtay A; Sher I; Tsang M; Dawid IB; Altuvia Y; Ron D
Proc Natl Acad Sci U S A; 2004 Feb; 101(5):1229-34. PubMed ID: 14742870
[TBL] [Abstract][Full Text] [Related]
3. The human sef-a isoform utilizes different mechanisms to regulate receptor tyrosine kinase signaling pathways and subsequent cell fate.
Ziv I; Fuchs Y; Preger E; Shabtay A; Harduf H; Zilpa T; Dym N; Ron D
J Biol Chem; 2006 Dec; 281(51):39225-35. PubMed ID: 17035228
[TBL] [Abstract][Full Text] [Related]
4. [Expression of hSef and FGF-2 in epithelial ovarian tumor].
Feng QL; Shi HR; Qiao LJ; Zhao J
Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):770-4. PubMed ID: 22335910
[TBL] [Abstract][Full Text] [Related]
5. Similar expression to FGF (Sef) reduces endometrial adenocarcinoma cells proliferation via inhibiting fibroblast growth factor 2-mediated MAPK/ERK signaling pathway.
Zhang H; Zhao X; Yan L; Li M
Gynecol Oncol; 2011 Sep; 122(3):669-74. PubMed ID: 21663947
[TBL] [Abstract][Full Text] [Related]
6. Similar expression to FGF (Sef) inhibits fibroblast growth factor-induced tumourigenic behaviour in prostate cancer cells and is downregulated in aggressive clinical disease.
Darby S; Murphy T; Thomas H; Robson CN; Leung HY; Mathers ME; Gnanapragasam VJ
Br J Cancer; 2009 Dec; 101(11):1891-9. PubMed ID: 19888221
[TBL] [Abstract][Full Text] [Related]
7. Tyrosine 330 in hSef is critical for the localization and the inhibitory effect on FGF signaling.
Ren Y; Li Z; Rong Z; Cheng L; Li Y; Wang Z; Chang Z
Biochem Biophys Res Commun; 2007 Mar; 354(3):741-6. PubMed ID: 17266935
[TBL] [Abstract][Full Text] [Related]
8. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
[TBL] [Abstract][Full Text] [Related]
9. Loss of Sef (similar expression to FGF) expression is associated with high grade and metastatic prostate cancer.
Darby S; Sahadevan K; Khan MM; Robson CN; Leung HY; Gnanapragasam VJ
Oncogene; 2006 Jul; 25(29):4122-7. PubMed ID: 16474841
[TBL] [Abstract][Full Text] [Related]
10. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells.
Dong K; Wang R; Wang X; Lin F; Shen JJ; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Feb; 113(3):443-56. PubMed ID: 18327707
[TBL] [Abstract][Full Text] [Related]
11. Delivery of the gene encoding the tumor suppressor Sef into prostate tumors by therapeutic-ultrasound inhibits both tumor angiogenesis and growth.
Mishel S; Shneyer B; Korsensky L; Goldshmidt-Tran O; Haber T; Machluf M; Ron D
Sci Rep; 2017 Nov; 7(1):15060. PubMed ID: 29118380
[TBL] [Abstract][Full Text] [Related]
12. Disabled-2 inactivation is an early step in ovarian tumorigenicity.
Fazili Z; Sun W; Mittelstaedt S; Cohen C; Xu XX
Oncogene; 1999 May; 18(20):3104-13. PubMed ID: 10340382
[TBL] [Abstract][Full Text] [Related]
13. Loss of expression of tropomyosin-1, a novel class II tumor suppressor that induces anoikis, in primary breast tumors.
Raval GN; Bharadwaj S; Levine EA; Willingham MC; Geary RL; Kute T; Prasad GL
Oncogene; 2003 Sep; 22(40):6194-203. PubMed ID: 13679858
[TBL] [Abstract][Full Text] [Related]
14. Cell growth stimulation by CRASH, an asparaginase-like protein overexpressed in human tumors and metastatic breast cancers.
Weidle UH; Evtimova V; Alberti S; Guerra E; Fersis N; Kaul S
Anticancer Res; 2009 Apr; 29(4):951-63. PubMed ID: 19414332
[TBL] [Abstract][Full Text] [Related]
15. Imatinib mesylate inhibits proliferation and exerts an antifibrotic effect in human breast stroma fibroblasts.
Gioni V; Karampinas T; Voutsinas G; Roussidis AE; Papadopoulos S; Karamanos NK; Kletsas D
Mol Cancer Res; 2008 May; 6(5):706-14. PubMed ID: 18505916
[TBL] [Abstract][Full Text] [Related]
16. Active (p)CrkL is overexpressed in human malignancies: potential role as a surrogate parameter for therapeutic tyrosine kinase inhibition.
Singer CF; Hudelist G; Lamm W; Mueller R; Handl C; Kubista E; Czerwenka K
Oncol Rep; 2006 Feb; 15(2):353-9. PubMed ID: 16391854
[TBL] [Abstract][Full Text] [Related]
17. hSef co-localizes and interacts with Ras in the inhibition of Ras/MAPK signaling pathway.
Ren Y; Cheng L; Rong Z; Li Z; Li Y; Li H; Wang Z; Chang Z
Biochem Biophys Res Commun; 2006 Sep; 347(4):988-93. PubMed ID: 16859641
[TBL] [Abstract][Full Text] [Related]
18. Reduced expression of N-Myc downstream-regulated gene 2 in human thyroid cancer.
Zhao H; Zhang J; Lu J; He X; Chen C; Li X; Gong L; Bao G; Fu Q; Chen S; Lin W; Shi H; Ma J; Liu X; Ma Q; Yao L
BMC Cancer; 2008 Oct; 8():303. PubMed ID: 18940011
[TBL] [Abstract][Full Text] [Related]
19. Expression of transmembrane protein tyrosine phosphatase gamma (PTPgamma) in normal and neoplastic human tissues.
Vezzalini M; Mombello A; Menestrina F; Mafficini A; Della Peruta M; van Niekerk C; Barbareschi M; Scarpa A; Sorio C
Histopathology; 2007 Apr; 50(5):615-28. PubMed ID: 17394498
[TBL] [Abstract][Full Text] [Related]
20. Müllerian inhibiting substance type II receptor (MISIIR): a novel, tissue-specific target expressed by gynecologic cancers.
Bakkum-Gamez JN; Aletti G; Lewis KA; Keeney GL; Thomas BM; Navarro-Teulon I; Cliby WA
Gynecol Oncol; 2008 Jan; 108(1):141-8. PubMed ID: 17988723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
